Table 6 Performance of Approach A (Model 2) in defining the rate of patients unnecessarily explored or inappropriately unexplored

From: Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial

Model 2

PIV

Unnecessarily explored (1−NPV) (%)

Inappropriately unexplored (1−PPV) (%)

0

17.9

28.8

1

25.0

27.6

2

33.3

19.4

3

39.0

18.2

4

48.1

16.3

5

50.0

7.4

6

53.6

5.0

7

54.3

0

Back to article page